Increasing Lifestyle Diseases Propelling Generic Medicines Industry

The rise in lifestyle disease and epidemiological transition is boosting the generic medicine industry, says RNCOS in its latest research report.


Noida, Uttar Pradesh, May 31, 2017 /India PRwire/ -- With the change in eating patterns, and rural to urban migration, many of the new urban poor are encountering a double burden of disease. Also, the unique epidemiology pattern of diseases, varying across different socio economic group and provinces has driven the South African generics medicine market.

According to our latest report, "South Africa Generics Medicine Market Outlook 2022", generics drugs are struggling to gain a significant share in the domestic market due to competition from branded drugs, lack of awareness among the consumers, strong lobbying between physicians and doctors, and lack of promotion and quality issues. While the global generics market stands matured, the generics market in South Africa is expected to grow at a CAGR of around 11% during the forecasted period of 2017-2022.

Further, government's national health plans are also expected to boost demand for lower cost drugs, especially generics, due to its commitment to provide greater access to anti-retroviral (ARV) medication within the public health system to combat the HIV/AIDS pandemic. With the government initiatives, the generic drug market has expanded tenfold. Also, increasing demand for everyday medicines, and uneven supply, the need for more generic brands has become a paramount.

The private market for generic drugs is growing, as the higher prices paid by the private sector help to subsidize the low-cost generics made available to the public sector. With current leading players as Aspen and Adcock Ingram, the South African generic medicines market has grown intensely over the last few years.

For FREE SAMPLE of this report visit:

Check Related REPORTS on:

Notes to Editor


RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.

Journalists and Bloggers
Visit India PRwire for Journalists for releases, photos, email alerts and customized feeds just for Media.

If you have any query regarding information in the press releases, please contact the company listed in the press release itself. Please do not call India PRwire, we will be unable to assist you with your inquiry.

RNCOS E-Services Pvt. Ltd. recent press release(s)

RNCOS White Paper: The Indian Health Insurance Sector

"The standalone health insurance industry continues to show the fastest growth rate on account of constant innovation by the players, says RNCOS"

Global Parkinson's Disease Drugs Market to Reach Approximate Value of US$ 5 Billion by 2022

"Growing aged population, rising healthcare expenditure, and increasing awareness about Parkinson's disease treatment options, likely to drive the Global Parkinson's Disease Drugs Market", says RNCOS.

Increasing Consumer Preference of Healthy Snacks Propelling Gourmet Popcorn Industry

Gourmet popcorns are becoming the consumers preference as a healthy snacks, says RNCOS in its latest research report.

Usage of Nanomaterial Propelling the Europe Cosmeceutical Market

Increased usage of nonmaterial in cosmetic products is driving the cosmeceutical market, says RNCOS in its latest research report.

Global Hemophilia Therapeutics Market to Reach US$ 13 Billion by 2022

"Grants and tax credits, rising healthcare expenditure, and increasing awareness about hemophilia likely to drive the Global Hemophilia Therapeutics Market", says RNCOS.